Triemli Hospital   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Switzerland (1889)

Organization Overview

First Clinical Trial
2003
NCT00439855
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Departement of Anaesthesia and Intensive Care,Triemli Hospital, Zurich, Switzerland | Department of Ophthalmology, Triemli Hospital Zuerich | Division of Cardiology Triemli Hospital Zurich | Institute of Anesthesiology and Intensive Care Medicine Triemli City Hospital Zurich | PD Dr. med. Stephan Michels | Triemli Hospital | Triemli Hospital Zurich, Switzerland | TriemliSpital

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 4)

Coronary Artery Disease (Phase 4)

Diabetic Retinopathy (Phase 1)

Fractures, Bone (Phase 3)

Hip Fractures (Phase 3)

Ileus (Phase 4)

Neoplastic Cells, Circulating (Phase 4)

Pancreatic Neoplasms (Phase 4)

Retinal Diseases (Phase 1)

Shock (Phase 2)

Shock, Septic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 14